Browsing by Contributors Ludwig, Heinz

فهرست الفبایی 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 8 of 8
PreviewIssue DateTitleContributor(s)
2019 BloodJournalofHematology Volume 133 Issue 2 January (7).pdf.jpg2019Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: A subgroup analysis of ENDEAVORDimopoulos, Meletios; Siegel, David; White, Darrell J.; Boccia, Ralph; Iskander, Karim S.; Yang, Zhao; Kimball, Amy S.; Mezzi, Khalid; Ludwig, Heinz; Niesvizky, Ruben
2016 JOC Volume 34 Issue 32 November (2).pdf.jpg2016Health-Related Quality-of-Life Results From the Open-Label , Randomized , Phase III ASPIRE Trial Evaluating Car fi lzomib , Lenalidomide , and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple MyelomaStewart, A Keith; Dimopoulos, Meletios A; Spi, Ivan; Oriol, Albert; Roman, H; Rosiñol, Laura; Siegel, David S; Niesvizky, Ruben; Jakubowiak, Andrzej J; San-miguel, Jesus F; Ludwig, Heinz; Buchanan, Jacqui; Cocks, Kim; Yang, Xinqun; Xing, Biao; Zojwalla, Naseem; Tonda, Ma
2017 BJH Volume 129 Issue 17 April (8).pdf.jpg2017How I manage the toxicities of myeloma drugsDelforge, Michel; Ludwig, Heinz
2018 JCO Volume 36 Issue 8 March (13).pdf.jpg2018Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myelomaSiegel, David S.; Dimopoulos, Meletios a.; Ludwig, Heinz; Facon, Thierry; Goldschmidt, Hartmut; Jakubowiak, Andrzej; San-Miguel, Jesus; Obreja, Mihaela; Blaedel, Julie; Stewart, a. Keith
2016 JCO Volume 34 Issue 13 May (5).pdf.jpg2016International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal ImpairmentDimopoulos, Meletios A; Sonneveld, Pieter; Leung, Nelson; Merlini, Giampaolo; Ludwig, Heinz; Kastritis, Efstathios; Goldschmidt, Hartmut; Joshua, Douglas; Orlowski, Robert Z; Powles, Raymond; Vesole, David H; Garderet, Laurent; Einsele, Hermann; Palumbo, Antonio; Cavo,
2014medicine article k (845).pdf.jpg2014Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.Benboubker, Lotfi; Dimopoulos, Meletios a; Dispenzieri, Angela; Catalano, John; Belch, Andrew R; Cavo, Michele; Pinto, Antonello; Weisel, Katja; Ludwig, Heinz; Bahlis, Nizar; Banos, Anne; Tiab, Mourad; Delforge, Michel; Cavenagh, Jamie; Geraldes, Catarina; Lee, Je-jung
2017 BJH Volume 178 Issue 4 August (12).pdf.jpg2017Management of adverse events associated with ixazomib plus lenalidomide / dexamethasone in relapsed / refractory multiple myelomaKumar, Shaji; Moreau, Philippe; Hari, Parameswaran; Ludwig, Heinz; Masszi, Tamas; Roman, H
2017 BritishJHematology Volume 178 Issue 4 August (12).pdf.jpg2017Management of adverse events associated with ixazomib plus lenalidomide / dexamethasone in relapsed / refractory multiple myelomaKumar, Shaji; Moreau, Philippe; Hari, Parameswaran; Ludwig, Heinz; Masszi, Tamas; Roman, H